[Home ] [Archive]   [ فارسی ]  
:: Main :: About us :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Subscription::
News& Events::
Contact us::
Site Facilities::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Indexing
                        
..
:: Volume 10, Issue 3 (Autumn 2013) ::
Sci J Iran Blood Transfus Organ 2013, 10(3): 312-318 Back to browse issues page
Irradiation of blood products: one year experience in Tehran Blood Transfusion Center
M. Zadsar , H. Sadegh , M. Naseranipoor , B. Haji Beigi , S.M. Mirrezaie
Abstract:   (13736 Views)

  Abstract

 Background and Objectives

 Pre-transfusion inactivation of donor T-cells by irradiation is the method of choice for prevention of TA-GVHD. This study reviewed the usage of irradiated products in one year period in Tehran Blood Transfusion Center.

 Materials and Methods

 There were 1333 requests for irradiated blood products to be evaluated. The data including the quantity and type of irradiated products, patients’ age and indications were gathered. Descriptive statistical analysis was performed by SPSS 18 software.

 Results

 The requested irradiated products in the one-year period of time include platelets (71.3%), packed RBCs (28.1%), FFP (0.4%), paediatric bags (0.2%), and whole blood (0.1%). The age groups of patients having received irradiated products were adults (59.6%), children (25.9%), infants (6.5%), and neonates (3.3%). Indications of prescription consist of leukaemia/lymphoma and Hodgkin (49.6%), allogeneic and autologous bone marrow transplantation (17.7%), immunosuppressive therapy (9.6%), congenital immunodeficiency (8.6%), premature birth (7.6%), aplastic anaemia (6.5%), relatives designated donation (0.3%), and HLA matched plateletphaeresis (0.1%). The increasing trend in the quantity of requests of irradiated products and requesting hospitals was observed.

  

 Conclusions

 It is recommended that a higher number of hospitals and their staff be informed about irradiated products and their indications and the roles they have on the prevention of TA-GVHD.

  

Keywords: Graft-Versus-Host Disease, Transfusion Reaction, prevention
Full-Text [PDF 231 kb]   (3885 Downloads) |   |   Full-Text (HTML)  (5998 Views)  
Type of Study: Research | Subject: Blood transfusion medicine
Published: 2013/10/5
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Zadsar M, Sadegh H, Naseranipoor M, Haji Beigi B, Mirrezaie S. Irradiation of blood products: one year experience in Tehran Blood Transfusion Center. Sci J Iran Blood Transfus Organ 2013; 10 (3) :312-318
URL: http://bloodjournal.ir/article-1-801-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 10, Issue 3 (Autumn 2013) Back to browse issues page
فصلنامه پژوهشی خون Scientific Journal of Iran Blood Transfus Organ
The Scientific Journal of Iranian Blood Transfusion Organization - Copyright 2006 by IBTO
Persian site map - English site map - Created in 0.05 seconds with 39 queries by YEKTAWEB 4645